Moderna Inc (MRNA)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 52.28% | 65.90% | 31.55% | 21.77% | 31.25% | 37.54% | 56.69% | 64.71% | 71.21% | 78.48% | 81.73% | 84.31% | 85.24% | 84.81% | 79.11% | 65.38% | -125.48% | -1,209.47% | -788.52% | -1,153.05% |
| Operating profit margin | -122.17% | -53.05% | -91.75% | -99.69% | -62.10% | -29.30% | 4.89% | 32.82% | 50.08% | 64.09% | 70.19% | 74.12% | 74.97% | 69.09% | 61.58% | 31.48% | -278.02% | -1,111.34% | -905.80% | -1,397.18% |
| Pretax margin | -111.71% | -46.36% | -85.75% | -93.15% | -57.75% | -25.91% | 7.80% | 34.27% | 50.90% | 64.47% | 70.30% | 74.11% | 74.90% | 69.02% | 61.60% | 31.78% | -271.24% | -1,074.06% | -860.20% | -1,321.91% |
| Net profit margin | -110.28% | -43.81% | -116.13% | -115.77% | -69.06% | -38.10% | 11.51% | 32.53% | 44.46% | 56.90% | 63.07% | 66.74% | 68.80% | 64.10% | 56.37% | 29.71% | -272.16% | -1,075.70% | -859.97% | -1,320.33% |
1. Gross Profit Margin:
Moderna Inc's gross profit margin has shown a significant improvement from the negative numbers in 2020 to positive figures for the periods starting March 31, 2021. The margin has been consistently increasing since then, reaching a high of 85.24% by December 31, 2021. However, there has been a slight decline in the margin in the most recent quarters, falling to 52.28% by December 31, 2024. Overall, the company has demonstrated a strong ability to generate profits from its core operations.
2. Operating Profit Margin:
The operating profit margin of Moderna Inc has also exhibited a similar trend to the gross profit margin, with a transition from negative values in 2020 to positive figures in 2021. The margin peaked at 74.97% by December 31, 2021, before declining in the subsequent periods. The company's operating profitability faced challenges in the first half of 2024, with margins turning negative again. This indicates a need for the company to closely monitor and manage its operating expenses to sustain profitability.
3. Pretax Margin:
Modern Inc's pretax margin has followed a comparable pattern to the operating profit margin, showing improvement over the years but experiencing a decline in the latter half of 2023 and 2024. The company achieved a peak pretax margin of 74.90% by December 31, 2021, however, faced a substantial decrease to -111.71% by December 31, 2024. This indicates potential issues with the company's ability to control its pre-tax expenses, which may impact its overall financial health.
4. Net Profit Margin:
The net profit margin of Moderna Inc reflects the company's ability to generate profits after accounting for all expenses, including taxes. Similar to the other profitability ratios, the net profit margin improved from negative values in 2020 to positive figures in 2021. However, the margin has shown fluctuations in the latter periods, with a significant decline to -110.28% by December 31, 2024. This suggests that while the company has been profitable in the past, there are challenges in maintaining consistent net profitability in recent quarters.
In conclusion, Moderna Inc has made notable strides in improving its profitability since 2020, as indicated by the positive margins achieved in the subsequent years. However, the recent decline in profitability ratios, especially in 2024, highlights the importance of cost management and operational efficiency for the company's sustainable growth and profitability.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -27.90% | -17.04% | -29.56% | -30.72% | -23.01% | -13.70% | 2.34% | 20.01% | 36.43% | 50.85% | 60.06% | 58.88% | 53.90% | 36.38% | 23.64% | 4.99% | -10.40% | -13.30% | -14.76% | -25.93% |
| Return on assets (ROA) | -25.18% | -14.07% | -37.42% | -35.67% | -25.58% | -17.82% | 5.52% | 19.83% | 32.34% | 45.15% | 53.97% | 53.02% | 49.46% | 33.75% | 21.64% | 4.71% | -10.18% | -12.88% | -14.01% | -24.51% |
| Return on total capital | -32.87% | -20.11% | -37.35% | -37.74% | -28.68% | -17.84% | 4.21% | 25.96% | 49.26% | 73.64% | 86.96% | 95.23% | 94.00% | 75.26% | 57.18% | 16.96% | -28.69% | -21.36% | -16.34% | -30.50% |
| Return on equity (ROE) | -32.67% | -18.65% | -50.09% | -46.56% | -34.03% | -25.76% | 7.12% | 25.36% | 43.73% | 65.39% | 78.15% | 85.73% | 86.26% | 69.75% | 52.13% | 15.59% | -29.17% | -21.70% | -16.57% | -30.88% |
Modern Inc's profitability ratios show a mixed performance over the analyzed period. The Operating return on assets (Operating ROA) improved significantly from negative values in early 2020 to reach a peak of 60.06% in June 2022, indicating that the company generated more operating income relative to its total assets. However, this ratio declined in the later periods but remained positive.
Similarly, the Return on assets (ROA) also exhibited a positive trend, turning from negative figures to peak at 53.97% in June 2022 before decreasing in the subsequent quarters. This ratio reflects the company's ability to generate profit from its total assets.
The Return on total capital and Return on equity (ROE) ratios showed a comparable trend, with both metrics improving from negative values to reach their highest levels in late 2021 and early 2022. These ratios indicate the efficiency of the company in generating returns for its total capital and equity holders, respectively.
Overall, the profitability ratios of Moderna Inc demonstrated an improvement in profitability and efficiency in generating returns during the analyzed period, although some fluctuations were observed in the later quarters.